← All trials
NCT03255941
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 19, 2018
- Primary completion
- Jul 15, 2018
- Completion date
- Jul 23, 2018
- First posted
- Aug 21, 2017
- Last posted
- Apr 13, 2021
- Enrollment
- 460
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- FHI 360Lead sponsor
- Aga Khan UniversityCollaborator
- FHI 360Overall official - principal investigator
- JhpiegoCollaborator
- United States Agency for International DevelopmentCollaborator
- FHI 360Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.